Islet Sciences Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Islet Sciences Inc Announces Closing of DiaKine Therapeutics Acquisition-India Pharma News
India Pharma News reported that Islet Sciences Inc is closing the acquisition of DiaKine Therapeutics, Inc. (DTI), a biopharmaceutical company developing new, proprietary drugs for unmet medical needs in diabetes and complications related to diabetes which is now the Company's wholly owned subsidiary.
Latest Developments for Islet Sciences Inc
Latest Key Developments in Biotechnology
- Share this
- Digg this